We are live on
!
Find out more
FA
FCG Advisors Portfolio holdings
AUM
$425M
1-Year Est. Return
12.09%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$24.5M
(+11%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
8.17%
Top 10 Holdings %
Top 10 Hldgs %
60.99%
Holding
128
New
18
Increased
62
Reduced
30
Closed
7
Top Buys
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.11M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$2.08M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$1.61M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$1.6M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$683K |
| 2 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$428K |
| 3 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$282K |
| 4 |
Constellation Brands
STZ
|
+$266K |
| 5 |
Union Pacific
UNP
|
+$254K |
Sector Composition
| 1 | Healthcare | 13.28% |
| 2 | Financials | 4.61% |
| 3 | Technology | 2.75% |
| 4 | Communication Services | 1.64% |
| 5 | Energy | 1.3% |
Similar funds
LWS
VCP
CCM
AIM
MGAI
CPF
IA
F
FCG Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, FCG Advisors held 128 positions worth $247M, up 11% from $223M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
FCG Advisors deployed $20.2M of net new capital in Q1 2017, opening 18 new positions and adding to 62 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 6,934 shares worth $1.43M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Celgene Corp, an estimated $683K trimmed.
- FCG Advisors's largest Q1 2017 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 6,934 shares worth $1.43M.
- FCG Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $2.93M increase.
- FCG Advisors's biggest Q1 2017 reduction was Celgene Corp, cutting an estimated $683K.
- FCG Advisors fully exited DIPLOMAT PHARMACY, INC. in Q1 2017, selling an estimated $428K.
- FCG Advisors's ten largest holdings make up 61% of its $247M portfolio in Q1 2017.
- FCG Advisors opened 18 new positions and closed 7 in Q1 2017.
- FCG Advisors's portfolio value rose 11% quarter-over-quarter to $247M.
Based on FCG Advisors's 13F filing for Q1 2017, filed 8 May 2017.